Market cap data unavailable. We couldn't positively verify this ticker's market cap is under $500M. Verify independently before trading.
BioAdaptives Inc.
- Market Cap
- Unavailable
- Volume
- 2.7M
Quote data as of 5:22 AM ET
About
BioAdaptives, Inc. investigates, markets, and distributes natural plant, algal, and mushroom-based products and medical devices for humans and animals. It offers nutraceutical products, such as dietary supplements. The company offers Human Clinical trial; Zeranovia, a natural ingredient and uses proprietary methods of optimizing the availability of nutrients in foods and beverages; Lung Flute, a medical device; and Xcellara, PawPa, and MyndMed. The company was formerly known as APEX 8 Inc. and changed its name to BioAdaptives, Inc. in September 2013. The company was incorporated in 2013 and is based in Las Vegas, Nevada.
Quick stats
Shares outstanding—
Computed float9.8M
Float sourceUnknown
Cash runway (months)Unknown
Dilution risk—
Has warrants—
Has convertibles—
Active shelf (Shelf registration (e.g. Form S-3) currently in effect — the company is pre-cleared to issue and sell new shares quickly. A standing dilution risk.)—
Active ATM (At-the-market offering — a program to sell newly issued shares directly into the open market at prevailing prices, diluting existing holders over time.)—
Key info
SectorConsumer Defensive
IndustryPackaged Foods
CIK (Central Index Key — the unique ID the SEC assigns to every filer. Use it to look up the company's filings on EDGAR.)0001575142